AltynGold's (LON:ALTN) earnings growth rate lags the 177% return delivered to shareholders
It might be of some concern to shareholders to see the AltynGold plc (LON:ALTN) share price down 18% in the last month. But that doesn't change the fact that the returns over the last year have been very strong. Like an eagle, the share price soared 177% in that time. So it may be that the share price is simply cooling off after a strong rise. Investors should be wondering whether the business itself has the fundamental value required to continue to drive gains.
While the stock has fallen 17% this week, it's worth focusing on the longer term and seeing if the stocks historical returns have been driven by the underlying fundamentals.
We've discovered 2 warning signs about AltynGold. View them for free.
To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.
During the last year AltynGold grew its earnings per share (EPS) by 133%. The share price gain of 177% certainly outpaced the EPS growth. So it's fair to assume the market has a higher opinion of the business than it a year ago.
The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).
We're pleased to report that the CEO is remunerated more modestly than most CEOs at similarly capitalized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. Dive deeper into the earnings by checking this interactive graph of AltynGold's earnings, revenue and cash flow.
It's nice to see that AltynGold shareholders have received a total shareholder return of 177% over the last year. That's better than the annualised return of 17% over half a decade, implying that the company is doing better recently. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Take risks, for example - AltynGold has 2 warning signs we think you should be aware of.
If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: many of them are unnoticed AND have attractive valuation).
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on British exchanges.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Sonic Healthcare (ASX:SHL) shareholders have endured a 8.4% loss from investing in the stock three years ago
As an investor its worth striving to ensure your overall portfolio beats the market average. But in any portfolio, there are likely to be some stocks that fall short of that benchmark. We regret to report that long term Sonic Healthcare Limited (ASX:SHL) shareholders have had that experience, with the share price dropping 17% in three years, versus a market return of about 44%. It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. During the three years that the share price fell, Sonic Healthcare's earnings per share (EPS) dropped by 28% each year. This fall in the EPS is worse than the 6% compound annual share price fall. This suggests that the market retains some optimism around long term earnings stability, despite past EPS declines. The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers). We like that insiders have been buying shares in the last twelve months. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. This free interactive report on Sonic Healthcare's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Sonic Healthcare, it has a TSR of -8.4% for the last 3 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments! Sonic Healthcare shareholders are up 10% for the year (even including dividends). Unfortunately this falls short of the market return. The silver lining is that the gain was actually better than the average annual return of 1.7% per year over five year. This suggests the company might be improving over time. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For example, we've discovered 1 warning sign for Sonic Healthcare that you should be aware of before investing here. If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: most of them are flying under the radar). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Australian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
5 hours ago
- Yahoo
Wayve CEO on London Self-Driving Cars Trial With Uber
Wayve Technologies CEO & Co-Founder Alex Kendall discusses the company's plans to remain "asset light" and adaptable for all car manufacturers. This comes after the startup's announcement earlier this week that they will be partnering with Uber to trial fully autonomous vehicles in London. The two companies have been working together for some time, with Uber owning a strategic investment in the London-based startup. Kendall speaks to Bloomberg's Tom Mackenzie at sidelines of Founders Forum in Oxfordshire, UK. Sign in to access your portfolio
Forbes
5 hours ago
- Forbes
US-China Trade Talks: The Limits Of Diplomacy
Delegations of China and the U.S. pose for a group photo prior to the first meeting of the ... More China-U.S. economic and trade consultation mechanism in London, Britain, June 9, 2025. The meeting opened here on Monday. Chinese Vice Premier He Lifeng, also a member of the Political Bureau of the Communist Party of China Central Committee, attended the meeting with U.S. representatives. (Photo by Li Ying/Xinhua via Getty Images) In early June 2025, officials from the U.S. and China convened in an attempt to to prevent salvage economic ties from spiraling out of control and causing significant damage to both economies. Talks took place in London's historic Lancaster House, as they sought to rescue an earlier negotiated tariff truce and defuse escalating export controls. The negotiations aimed to extend the 90-day pause on punitive tariffs agreed in Geneva, revive cross-border trade flows, and hammer out a framework on rare-earth minerals and high-end technology exports. However, the talks ultimately accomplished few tangible benefits that President Trump sought to originally gain from the implementation of these tariffs, namely to stem the flow of fentanyl, motivate companies to reshore to the US, and close the trade deficit. Instead, he temporarily paused these measures by both sides and returned to the dynamics prior to his 'Liberation Day' and the imposition of tariffs globally. The June 9 to 10 London talks — led by U.S. Treasury Secretary Scott Bessent, Commerce Secretary Howard Lutnick and USTR Jamieson Greer from the U.S. and China's Vice Premier He Lifeng and Commerce Minister Wang Wentao — were convened against a backdrop of deep mutual distrust. Since 2018, the two sides have imposed tit-for-tat duties, with U.S. tariffs on Chinese exports staying around 19-21% from the end of Trump's first term until the beginning of his second, and Beijing following suit with…. After Liberation Day, US tariffs reached a high of 145% before decreasing to 30%, while Beijing imposed a retaliatory tariff of 125% before settling at its current level of 10%.These actions have stifled more than $600 billion in bilateral trade and rattled global markets. At the same time, The Trumps' administration's erratic and inconsistent messaging has also allowed for Wall Street to start pricing in volatility. Moreover a new TACO theory emerged, 'TACO or Trump Always Chickens Out.' This asserts that despite Trumps tough trade policy rhetoric, when markets become too volatile Trump will always reverse course. US Reliance on Critical Rare Earth Metals US Reliance on Rare Earth Imports from China In April 2025, China further escalated tensions by instituting a requirement of export licenses for critical rare-earth minerals, resulting in a 20% year-on-year decrease in shipments to the U.S. and Europe. Due to China's dominance in rare earth exports to the US, this triggered alarms in various industries, most notably in the electric vehicle and aerospace sector. Meanwhile, Washington broadened its export curbs on advanced semiconductors, chip-making equipment, and aerospace components, with a particular intensification after the two countries' Geneva talks, amplifying China's sense of economic siege. Despite the high stakes, negotiators emerged from London with only a modest 'interim framework' rather than a sweeping accord. However, Trump still claimed in a Truth Social post that 'the relationship is excellent.' The enthusiasm from the president is in large part due to China agreeing to temporarily grant export licenses for rare-earth magnets and related components, enabling U.S. automakers such as Ford, GM, and Stellantis to replenish inventories after April's curbs. At the same time, the U.S. stopped short of lifting its tech export restrictions on AI chips and aerospace tools. Commerce Secretary Lutnick characterized the outcome as 'putting meat on the bones' of the May Geneva deal, while Ministry of Commerce spokesperson He Yidong stated the two sides reached a consensus framework to 'implement the important understandings' reached during the June 5 phone call between Trump and Xi. From an economic perspective, the London agreement delivered a short-lived reprieve. Following reports of the rare-earth license concession, global equity markets ticked higher, echoing relief seen after the Geneva truce. Yet core barriers remain firmly in place: U.S. base tariffs on Chinese goods remain near 30%, China's on U.S. exports linger around 10%, and neither side agreed to roll back its export-control regimes. Without a detailed enforcement mechanism or significant new commitments, the framework may merely defer a return to pre-Geneva duties once the 90-day window lapses in August. Current versus pre-Geneva Tariff Levels Geopolitical undercurrents will also further limit any long-term détente. In Washington, a bipartisan consensus has emerged around the need to 'de‐risk' critical supply chains, not merely as a commercial maneuver but as a national security imperative. Policymakers and industry leaders alike fear that overdependence on China for semiconductors, pharmaceuticals, rare‐earth minerals, and even basic manufacturing capacity leaves the United States dangerously exposed to coercive economic pressure or abrupt supply shocks. This conviction has translated into a suite of domestic incentives—ranging from the CHIPS and Science Act to expanded Defense Production Act authorities—designed to shore up American production of key inputs and diversify procurement to 'trusted' partners. On the other side of the Pacific, Chinese leadership interprets these U.S. measures as part of a long-standing containment strategy. Official rhetoric in Beijing routinely casts de-risking initiatives as destabilizing 'decoupling' efforts that threaten China's development model and tarnish the mutually beneficial aspects of economic integration. State media and senior diplomats argue that a sovereign nation, particularly one bearing the mantle of a developing‐country status, must safeguard its industrial base against foreign interference. Despite the rhetoric on economic self-reliance, both the U.S. and China have much to lose from a prolonged trade war. According to the military think tank RAND, 'roughly 40 percent of China's exports to the United States fall into categories where China supplies more than half of America's total imports.' Meanwhile, China is eager to gain access to GPUs and CPUs from American companies like NVIDIA and AMD to power its growing AI infrastructure. Even knowing this, leaders on both sides remain committed to showing strength and independence. Trump administration officials are wary of ceding control to China, while Beijing officials do not want to appear weak on the global stage. The talks, while cordial, still have not permanently de-escalated the trade war, with 30% and 10% baseline tariffs remaining on the American and Chinese sides, respectively. Furthermore, China has only agreed to a six-month license for American companies seeking to import rare earth minerals and magnets. Beyond the economic impact, the visa statuses of Chinese students in US universities will continue to remain uncertain as long as the trade war remains unresolved. As the two economic superpowers prepare for the current deadline on a comprehensive trade deal by August 10, the London talks underscore both the value and the limits of diplomacy: they bought time, but a durable resolution remains elusive. Special thanks to Jonah Kim, and Nathaniel Schochet, for their exceptional thought leadership, research, and editorial contributions to this article. Special thanks to Hanah Kim and Artem Valyaev Kunisky for assisting in providing info-graphics.
